Previous studies have reported that IL-33 acts as an endogenous “danger signal” or “alarmin” that may alert the immune system in response to inflammatory diseases [16], such as hypersensitive diseases like asthma [17], autoimmune diseases like rheumatoid arthritis [18], allergic rhinitis [19], and autoimmune conjunctivitis [20]. Here, IL33 is linked to autoimmune disease.